Back to Search
ANDREA BALDELLI, PHD
PHD
Student in an Organized Health Care Education/Training Program
NPI: 1891220091Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.
PMID 19259089·Br J Cancer·2009
8-other
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
PMID 18971936·Br J Cancer·2008
8-other
Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
PMID 18824450·Clin Lung Cancer·2008
3-trial
Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer.
PMID 18594216·Anticancer Drugs·2008
3-trial
Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
PMID 18269775·Clin Breast Cancer·2007
3-trial
A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.
PMID 17562239·Clin Lung Cancer·2007
3-trial
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.
PMID 16686939·BMC Cancer·2006
3-trial
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.
PMID 15770210·Br J Cancer·2005
8-other
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.
PMID 11875737·Br J Cancer·2002
8-other
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.
PMID 12177109·J Clin Oncol·2002
3-trial
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.
PMID 12085175·Br J Cancer·2002
3-trial
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
PMID 12075739·Ann Oncol·2002
3-trial
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
PMID 11870508·Br J Cancer·2002
3-trial
A systematic review of the role of pulmonary irradiation in the management of primary bone tumours.
PMID 11863105·Ann Oncol·2002
1-meta
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
PMID 11207039·Br J Cancer·2001
3-trial
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer.
PMID 11518545·BMC Cancer·2001
4-observational
Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
PMID 12113030·Expert Rev Anticancer Ther·2001
6-review
Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.
PMID 11311657·Crit Rev Oncol Hematol·2001
6-review
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
PMID 11300331·Ann Oncol·2001
8-other
Gastrointestinal cancer refractory to chemotherapy: a role for octreotide?
PMID 11275706·Chemotherapy·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- MASSACHUSETTS GENERAL HOSPITAL, 55 FRUIT STREET
BOSTON, MA 02114 - Phone
- (617) 726-3648
Quick Facts
- NPI
- 1891220091
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile